NCT02648711 2020-05-28Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid TumorsLumos PharmaPhase 1 Terminated41 enrolled
NCT00066625 2013-02-01Oxaliplatin and Bortezomib in Treating Patients With Advanced CancerNational Cancer Institute (NCI)Phase 1 Terminated30 enrolled